Nelson Shu-Sang Yee

Nelson Shu-Sang Yee is an Associate Professor of Medicine at Pennsylvania State University College of Medicine, where he leads the Gastrointestinal Oncology Research Program at Penn State Cancer Institute. He specializes in medical oncology with focus on cancers of the digestive system, including pancreatic, biliary, and gastrointestinal tract malignancies.

• Board-certified Medical Oncologist
• Team Leader, Gastrointestinal Oncology
• Academic Editor roles: Disease Markers, Molecular and Cellular Oncology

Education:

• Dual B.S. (Pharmacy and Chemistry), Summa Cum Laude, Valedictorian, Massachusetts College of Pharmacy
• MD and PhD, Cornell University Medical College and Memorial Sloan Kettering Cancer Center
• Internal Medicine Residency, Hematology/Oncology Fellowship, Hospital of the University of Pennsylvania

Research Interests center on clinical evaluation of cancer biomarkers, therapeutic targets in digestive cancers, and precision oncology. He directs multiple clinical electives and clerkships in hematology/oncology and contributes to translational medicine through peer-reviewed publications and editorial leadership.

Scientific Awards include NIH funding, American Cancer Society grants, and recognition in multiple academic honor societies. His work appears in journals like Biomedicines, Frontiers in Immunology, and Journal of Clinical Medicine, covering topics from pancreatic cancer to immunotherapy advancements.

As a principal investigator, Dr. Yee has secured grants from the National Institute of Diabetes and Digestive and Kidney Diseases for zebrafish exocrine pancreas research, contributing to understanding pancreatic organogenesis and cancer pathogenesis.